Prophylactic laser treatment hastens choroidal neovascularization in unilateral age-related maculopathy: Final results of the drusen laser study - Commentary

Evidence-Based Ophthalmology

Volumn 7, Issue 3, 2006, Pages 135-137

  Kertes, Peter J ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INCIDENCE; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 33750343521     PISSN: 15559203     EISSN: 15559211     Source Type: Journal    
DOI: None     Document Type: Note

References (5)

1. Bressler SB, Maguire MG, Bressler NM, et al. Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group. Arch Ophthalmol. 1990;108:1442-1447.
2. Wetzig PC. Treatment of drusen-related ageing macular degeneration by photocoagulation. Trans Am Ophthalmol Soc. 1988;86:276-290.
3. Sigelman J. Foveal drusen resorption one year after perifoveal laser photocoagulation. Ophthalmology. 1991;98:1379-1383.
4. The Choroidal Neovascularization Prevention Trial Research Group. Laser treatment in fellow eyes with large drusen: updated findings from a pilot randomized clinical trial. Ophthalmology. 2003;110:971-978.
5. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS Report No. 8. Arch Ophthalmol. 2001;119:1417-1436.